Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00000767
What this trial is testing

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT00000746
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)WithdrawnNCT00389103
What this trial is testing

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Who this might be right for
SmallpoxAtopic Dermatitis
Sanofi Pasteur, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Early research (Phase 1)Study completedNCT00003761
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07190833
What this trial is testing

OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Who this might be right for
Treatment-Refractory Solid Tumors
Bionoxx Inc. 27
Testing effectiveness (Phase 2)Study completedNCT00437021
What this trial is testing

MVA Post-Event: Administration Timing and Boost Study

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 226
Testing effectiveness (Phase 2)Study completedNCT00038987
What this trial is testing

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 330
Not applicableUnknownNCT04022148
What this trial is testing

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Who this might be right for
Cancer of CervixVaccinia
University of Fukui 2,800
Not applicableStudy completedNCT00407069
What this trial is testing

Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus

Who this might be right for
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 286
Testing effectiveness (Phase 2)Study completedNCT00820846
What this trial is testing

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 299
Testing effectiveness (Phase 2)Study completedNCT00053482
What this trial is testing

Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults

Who this might be right for
Smallpox
Emergent BioSolutions 357
Early research (Phase 1)Study completedNCT01147991
What this trial is testing

Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer

Who this might be right for
Gastric CancerHead and Neck CancerLymphoma+2 more
Cancer Research UK 16
Testing effectiveness (Phase 2)WithdrawnNCT00227474
What this trial is testing

S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Large-scale testing (Phase 3)Study completedNCT02543268
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Crucell Holland BV 329
Early research (Phase 1)Study completedNCT00002261
What this trial is testing

A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Large-scale testing (Phase 3)Active Not RecruitingNCT06223919
What this trial is testing

Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia

Who this might be right for
Monkeypox
Universidad Nacional de Colombia 8,686
Early research (Phase 1)Study completedNCT00000630
What this trial is testing

Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 35
Not applicableStudy completedNCT00515047
What this trial is testing

Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 900
Next Page